Burkitt's lymphoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| (11 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Burkitt's lymphoma}} | {{Burkitt's lymphoma}} | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}}, {{kakbar}} | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of Burkitt's lymphoma | Common [[risk factors]] in the development of Burkitt's lymphoma are [[HIV]]/[[AIDS]] and post-transplant [[immunosuppression]]. There are no established [[risk factors]] for childhood Burkitt's lymphoma. | ||
==Risk Factors== | ==Risk Factors== | ||
Common risk factors in the development of Burkitt's lymphoma may | Common [[risk factors]] in the development of Burkitt's lymphoma may include:<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | ||
* [[HIV]]/[[AIDS]] | * [[HIV]]/[[AIDS]]<ref name="pmid29663523">{{cite journal| author=Meister A, Hentrich M, Wyen C, Hübel K| title=Malignant lymphoma in the HIV-positive patient. | journal=Eur J Haematol | year= 2018 | volume= 101 | issue= 1 | pages= 119-126 | pmid=29663523 | doi=10.1111/ejh.13082 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29663523 }} </ref> | ||
* [[Post-transplant]] | * [[Immunosuppression|Post-transplant immunosuppression]]<ref name="pmid23466659">{{cite journal| author=Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD| title=Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature. | journal=Case Rep Oncol | year= 2013 | volume= 6 | issue= 1 | pages= 6-14 | pmid=23466659 | doi=10.1159/000346346 | pmc=3573821 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23466659 }} </ref> | ||
*Solid organ [[transplant]]<ref name="pmid23386365">{{cite journal| author=Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD et al.| title=Burkitt lymphoma risk in U.S. solid organ transplant recipients. | journal=Am J Hematol | year= 2013 | volume= 88 | issue= 4 | pages= 245-50 | pmid=23386365 | doi=10.1002/ajh.23385 | pmc=3608801 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23386365 }} </ref> | |||
* [[Malaria]]<ref name="pmid29676453">{{cite journal| author=Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN et al.| title=Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink. | journal=Br J Haematol | year= 2018 | volume= 181 | issue= 4 | pages= 505-514 | pmid=29676453 | doi=10.1111/bjh.15229 | pmc=5980720 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29676453 }} </ref> | |||
==References== | ==References== | ||
| Line 20: | Line 21: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 04:48, 18 January 2019
|
Burkitt's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Burkitt's lymphoma risk factors On the Web |
|
American Roentgen Ray Society Images of Burkitt's lymphoma risk factors |
|
Risk calculators and risk factors for Burkitt's lymphoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]
Overview
Common risk factors in the development of Burkitt's lymphoma are HIV/AIDS and post-transplant immunosuppression. There are no established risk factors for childhood Burkitt's lymphoma.
Risk Factors
Common risk factors in the development of Burkitt's lymphoma may include:[1]
References
- ↑ 1.0 1.1 Karimi P, Birmann BM, Anderson LA, McShane CM, Gadalla SM, Sampson JN; et al. (2018). "Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink". Br J Haematol. 181 (4): 505–514. doi:10.1111/bjh.15229. PMC 5980720. PMID 29676453.
- ↑ Meister A, Hentrich M, Wyen C, Hübel K (2018). "Malignant lymphoma in the HIV-positive patient". Eur J Haematol. 101 (1): 119–126. doi:10.1111/ejh.13082. PMID 29663523.
- ↑ Naik S, Tayapongsak K, Robbins K, Manavi CK, Pettenati MJ, Grier DD (2013). "Burkitt's Lymphoma Presenting as Late-Onset Posttransplant Lymphoproliferative Disorder following Kidney and Pancreas Transplantation: Case Report and Review of the Literature". Case Rep Oncol. 6 (1): 6–14. doi:10.1159/000346346. PMC 3573821. PMID 23466659.
- ↑ Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD; et al. (2013). "Burkitt lymphoma risk in U.S. solid organ transplant recipients". Am J Hematol. 88 (4): 245–50. doi:10.1002/ajh.23385. PMC 3608801. PMID 23386365.